BHST — Bioharvest Sciences Share Price
0.000.00%
Last trade - 00:00- $108.30m
- $119.73m
- $25.19m
- 50
- 13
- 64
- 37
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 81.43 | ||
| Price to Tang. Book | 81.43 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -65.06% | ||
| Return on Equity | n/a | ||
| Operating Margin | -27.75% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.4 | 2.1 | 5.5 | 12.67 | 25.19 | 40.19 | 63.57 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioHarvest Sciences Inc. is a Botanical Synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 19th, 2013
- Public Since
- August 5th, 2015
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 17,327,716
- Address
- 1140 - 625 Howe Street, VANCOUVER, V6C 2T6
- Web
- https://bioharvest.com/about/
- Phone
- +1 6046221186
- Contact
- David Ryan
- Auditors
- BDO & Co.
Upcoming Events for BHST
Q1 2025 Bioharvest Sciences Inc Earnings Release
Bioharvest Sciences Inc Annual Shareholders Meeting
Bioharvest Sciences Inc Extraordinary Shareholders Meeting
Q2 2025 Bioharvest Sciences Inc Earnings Release
Similar to BHST
Above Food Ingredients
NASDAQ Global Market
Australian Oilseeds Holdings
NASDAQ Global Market
Bridgford Foods
NASDAQ Global Market
Freshpet
NASDAQ Global Market
Lifeway Foods
NASDAQ Global Market
FAQ
What is the Bioharvest Sciences share price?
As of Today at 19:35 UTC, shares in Bioharvest Sciences are trading at $6.55. This share price information is delayed by 15 minutes.
How has the Bioharvest Sciences share price performed this year?
Shares in Bioharvest Sciences last closed at $6.55 and the price had moved by +1.16% over the past 365 days. In terms of relative price strength the Bioharvest Sciences share price has underperformed the S&P500 Index by -6.63% over the past year.
What are the analyst and broker recommendations for Bioharvest Sciences?
The overall consensus recommendation for Bioharvest Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Bioharvest Sciences dividend yield?
Bioharvest Sciences does not currently pay a dividend.
Does Bioharvest Sciences pay a dividend?
Bioharvest Sciences does not currently pay a dividend.
When does Bioharvest Sciences next pay dividends?
Bioharvest Sciences does not currently pay a dividend.
How do I buy Bioharvest Sciences shares?
To buy shares in Bioharvest Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Bioharvest Sciences?
As of the previous close price of $6.55, shares in Bioharvest Sciences had a market capitalisation of $108.30m.
Where are Bioharvest Sciences shares listed?
Here are the trading details for Bioharvest Sciences:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: BHST
What kind of share is Bioharvest Sciences?
Based on an overall assessment of its quality, value and momentum Bioharvest Sciences is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Bioharvest Sciences share price forecast for 2025?
The analyst consensus target price for shares in Bioharvest Sciences is $14.66. That is 123.89% above the last closing price of $6.55.
Analysts covering Bioharvest Sciences currently have a consensus Earnings Per Share (EPS) forecast of -$0.24 for the next financial year.
Find out moreWhat is the trend in the Bioharvest Sciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioharvest Sciences. Over the past six months, its share price has outperformed the S&P500 Index by +43.83%.
As of the last closing price of $6.55, shares in Bioharvest Sciences were trading +13.8% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Bioharvest Sciences PE Ratio?
The Bioharvest Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Bioharvest Sciences?
We do not have data on Bioharvest Sciences' directors